Explore
Validate
Learn
Western blot
ELISAAntibody data
- Antibody Data
- Antigen structure
- References [7]
- Comments [0]
- Validations
- Western blot [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 17626-1-AP - Provider product page
- Provider
- Proteintech Group
- Proper citation
- Proteintech Cat#17626-1-AP, RRID:AB_2126105
- Product name
- CD127/IL-7R antibody
- Antibody type
- Polyclonal
- Description
- CD127/IL-7R antibody (Cat. #17626-1-AP) is a rabbit polyclonal antibody that shows reactivity with human, mouse and has been validated for the following applications: FC, IP, WB,ELISA.
- Reactivity
- Human, Mouse
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 20ul, 150ul
Submitted references Translation factor eIF4G2 directs CD8(+) T cell lineage commitment by selectively enabling the IL-7 receptor response.
Identification of a Gene Expression Signature to Predict the Risk of Abdominal Aortic Aneurysm in Psoriasis Patients.
Targeting BATF2-RGS2 axis reduces T-cell exhaustion and restores anti-tumor immunity.
Deletion of thymic myoid cells regulates the thymic microenvironment involved in the progression of tumor-associated myasthenia gravis.
CD146(+) CAFs mediate immunosuppression in gastric cancer via COL4A1: potential therapeutic targets.
TGFß1 Stimulates Lymphatic Endothelial Cells to Produce IL7 and IL15, Which Act as Chemotactic Factors for Breast Cancer Cells with Mesenchymal Properties.
TET2 is involved in DNA hydroxymethylation, cell proliferation and inflammatory response in keratinocytes.
Cui J, Zhang X, Yang Y, Shan L, Li Y, Jiang L, Xie W, Jin T, Lang X
iScience 2026 Apr 17;29(4):115313
iScience 2026 Apr 17;29(4):115313
Identification of a Gene Expression Signature to Predict the Risk of Abdominal Aortic Aneurysm in Psoriasis Patients.
Lyu X, Tang Q, Zou Y, Liu X
Clinical, cosmetic and investigational dermatology 2025;18:961-978
Clinical, cosmetic and investigational dermatology 2025;18:961-978
Targeting BATF2-RGS2 axis reduces T-cell exhaustion and restores anti-tumor immunity.
Gu X, Gao C, Su X, Zhu Y, Fang Q, Yu J, Wang Z, Zhao D, Zhang W
Molecular cancer 2025 May 30;24(1):157
Molecular cancer 2025 May 30;24(1):157
Deletion of thymic myoid cells regulates the thymic microenvironment involved in the progression of tumor-associated myasthenia gravis.
Hu B, Luo Y, Ding X, Sun M, Niu L
Clinical and experimental immunology 2025 Jan 21;219(1)
Clinical and experimental immunology 2025 Jan 21;219(1)
CD146(+) CAFs mediate immunosuppression in gastric cancer via COL4A1: potential therapeutic targets.
Chen J, Xu P, Wang Q, Dai J, Liang S, Yang S, Xie G, Li X, Wang Y, Hua H, Ping X, Shen J, Shen L
Journal for immunotherapy of cancer 2025 Dec 21;13(12)
Journal for immunotherapy of cancer 2025 Dec 21;13(12)
TGFß1 Stimulates Lymphatic Endothelial Cells to Produce IL7 and IL15, Which Act as Chemotactic Factors for Breast Cancer Cells with Mesenchymal Properties.
Giotopoulou N, Shi W, Parniewska MM, Sun W, Fuxe J
Journal of mammary gland biology and neoplasia 2023 Dec 6;28(1):25
Journal of mammary gland biology and neoplasia 2023 Dec 6;28(1):25
TET2 is involved in DNA hydroxymethylation, cell proliferation and inflammatory response in keratinocytes.
Liu X, Wang X, Liu N, Zhu K, Zhang S, Duan X, Huang Y, Jin Z, Jaypaul H, Wu Y, Chen H
Molecular medicine reports 2020 Apr;21(4):1941-1949
Molecular medicine reports 2020 Apr;21(4):1941-1949
No comments: Submit comment
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- The CD127/IL7R antibody from Proteintech is a rabbit polyclonal antibody to a recombinant protein of human CD127/IL7R. This antibody recognizes human, mouse antigen. The CD127/IL7R antibody has been validated for the following applications: ELISA, WB analysis.
